Tus Pharmaceutical Group Co Ltd (000590) - Total Liabilities
Based on the latest financial reports, Tus Pharmaceutical Group Co Ltd (000590) has total liabilities worth CN¥333.17 Million CNY (≈ $48.75 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tus Pharmaceutical Group Co Ltd - Total Liabilities Trend (1995–2025)
This chart illustrates how Tus Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 000590 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tus Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tus Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
JTL Industries Ltd
NSE:JTLIND
|
India | Rs2.74 Billion |
|
Steelcast Limited
NSE:STEELCAS
|
India | Rs508.80 Million |
|
Unitech Computer Co Ltd
TW:2414
|
Taiwan | NT$6.48 Billion |
|
Ld Intelligent Technology Co Ltd
SHE:300883
|
China | CN¥1.24 Billion |
|
Rotshtein
TA:ROTS
|
Israel | ILA1.57 Billion |
|
Materialise NV
NASDAQ:MTLS
|
USA | $162.93 Million |
|
Rossari Biotech Limited
NSE:ROSSARI
|
India | Rs8.36 Billion |
|
Shenzhen Ecobeauty Co Ltd
SHE:000010
|
China | CN¥2.31 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Tus Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 000590 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tus Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tus Pharmaceutical Group Co Ltd (1995–2025)
The table below shows the annual total liabilities of Tus Pharmaceutical Group Co Ltd from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥339.98 Million ≈ $49.75 Million |
-17.52% |
| 2024-12-31 | CN¥412.18 Million ≈ $60.32 Million |
-2.54% |
| 2023-12-31 | CN¥422.92 Million ≈ $61.89 Million |
-8.90% |
| 2022-12-31 | CN¥464.26 Million ≈ $67.94 Million |
+62.61% |
| 2021-12-31 | CN¥285.50 Million ≈ $41.78 Million |
+15.46% |
| 2020-12-31 | CN¥247.27 Million ≈ $36.18 Million |
+10.10% |
| 2019-12-31 | CN¥224.58 Million ≈ $32.86 Million |
-5.19% |
| 2018-12-31 | CN¥236.88 Million ≈ $34.66 Million |
-18.43% |
| 2017-12-31 | CN¥290.40 Million ≈ $42.50 Million |
-20.81% |
| 2016-12-31 | CN¥366.72 Million ≈ $53.66 Million |
-3.91% |
| 2015-12-31 | CN¥381.64 Million ≈ $55.85 Million |
-5.23% |
| 2014-12-31 | CN¥402.71 Million ≈ $58.93 Million |
+42.28% |
| 2013-12-31 | CN¥283.05 Million ≈ $41.42 Million |
+25.56% |
| 2012-12-31 | CN¥225.44 Million ≈ $32.99 Million |
-10.41% |
| 2011-12-31 | CN¥251.62 Million ≈ $36.82 Million |
-13.19% |
| 2010-12-31 | CN¥289.85 Million ≈ $42.41 Million |
+1.66% |
| 2009-12-31 | CN¥285.11 Million ≈ $41.72 Million |
+14.72% |
| 2008-12-31 | CN¥248.53 Million ≈ $36.37 Million |
+2.97% |
| 2007-12-31 | CN¥241.37 Million ≈ $35.32 Million |
-11.94% |
| 2006-12-31 | CN¥274.10 Million ≈ $40.11 Million |
-30.79% |
| 2005-12-31 | CN¥396.04 Million ≈ $57.95 Million |
-3.18% |
| 2004-12-31 | CN¥409.06 Million ≈ $59.86 Million |
-3.98% |
| 2003-12-31 | CN¥426.00 Million ≈ $62.34 Million |
-4.04% |
| 2002-12-31 | CN¥443.96 Million ≈ $64.96 Million |
+6.62% |
| 2001-12-31 | CN¥416.40 Million ≈ $60.93 Million |
+62.51% |
| 2000-12-31 | CN¥256.24 Million ≈ $37.50 Million |
+2.88% |
| 1999-12-31 | CN¥249.06 Million ≈ $36.45 Million |
+83.72% |
| 1998-12-31 | CN¥135.56 Million ≈ $19.84 Million |
+2.52% |
| 1997-12-31 | CN¥132.23 Million ≈ $19.35 Million |
+190.34% |
| 1996-12-31 | CN¥45.54 Million ≈ $6.66 Million |
-39.87% |
| 1995-12-31 | CN¥75.74 Million ≈ $11.08 Million |
-- |
About Tus Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offer… Read more